Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Libra

Showing results (121-130 of 293) with videos related to

Pageof 30
Sort By:
International Journal of Molecular Medicine|May 28, 2011
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patientsMarco Donia, Massimiliano Anzaldi, Roberto Di Marco, et al.
Molecular Medicine Reports|August 4, 2012
BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review)Giulia Costanza Leonardi, Saverio Candido, Maurizio Carbone, et al.
Oncology Letters|February 13, 2016
Molecular-targeted therapy for elderly patients with advanced non-small cell lung cancerGiovanna Antonelli, Massimo Libra, Vincenzo Panebianco, et al.
Tumori|August 12, 2003
Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three casesMassimo Libra, Roberto Sorio, Angela Buonadonna, et al.
Cell Cycle (Georgetown, Tex.)|March 24, 2009
PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approachesGiovanni Ligresti, Loredana Militello, Linda S Steelman, et al.
Molecular Medicine Reports|April 12, 2011
Combining chemo-, hormonal and targeted therapies to treat breast cancer (Review)Linda S Steelman, Patrick M Navolanic, Richard A Franklin, et al.
Molecular Medicine Reports|April 12, 2011
Breast cancer: Molecular basis and therapeutic strategies (Review)Giovanni Ligresti, Massimo Libra, Loredana Militello, et al.
BMC Cancer|March 26, 2004
Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapyMassimo Libra, Patrick M Navolanic, Renato Talamini, et al.
British Journal of Haematology|August 16, 2002
Differentiation between non-Hodgkin's lymphoma recurrence and second primary lymphoma by VDJ rearrangement analysisMassimo Libra, Valli De Re, Daniela Gasparotto, et al.
International Journal of Oncology|December 28, 2011
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review)Sameh Hafsi, Franca Maria Pezzino, Saverio Candido, et al.
Pageof 30

Showing results (121-130 of 293) with videos related to

Sort By:
Pageof 30
International Journal of Molecular Medicine|May 28, 2011
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patientsMarco Donia, Massimiliano Anzaldi, Roberto Di Marco, et al.
Molecular Medicine Reports|August 4, 2012
BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review)Giulia Costanza Leonardi, Saverio Candido, Maurizio Carbone, et al.
Oncology Letters|February 13, 2016
Molecular-targeted therapy for elderly patients with advanced non-small cell lung cancerGiovanna Antonelli, Massimo Libra, Vincenzo Panebianco, et al.
Tumori|August 12, 2003
Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three casesMassimo Libra, Roberto Sorio, Angela Buonadonna, et al.
Cell Cycle (Georgetown, Tex.)|March 24, 2009
PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approachesGiovanni Ligresti, Loredana Militello, Linda S Steelman, et al.
Molecular Medicine Reports|April 12, 2011
Combining chemo-, hormonal and targeted therapies to treat breast cancer (Review)Linda S Steelman, Patrick M Navolanic, Richard A Franklin, et al.
Molecular Medicine Reports|April 12, 2011
Breast cancer: Molecular basis and therapeutic strategies (Review)Giovanni Ligresti, Massimo Libra, Loredana Militello, et al.
BMC Cancer|March 26, 2004
Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapyMassimo Libra, Patrick M Navolanic, Renato Talamini, et al.
British Journal of Haematology|August 16, 2002
Differentiation between non-Hodgkin's lymphoma recurrence and second primary lymphoma by VDJ rearrangement analysisMassimo Libra, Valli De Re, Daniela Gasparotto, et al.
International Journal of Oncology|December 28, 2011
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review)Sameh Hafsi, Franca Maria Pezzino, Saverio Candido, et al.
Pageof 30